acetohydroxamic acid 250 MG Oral Tablet [Lithostat]

RxNorm concept 213557, branded drug (sbd). Prescribable name: Lithostat 250 MG Oral Tablet.

RxCUI: 213557
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/213557 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

acetohydroxamic acid 16728

Other names

Lithostat 250 MG Oral Tablet

Related concepts

acetohydroxamic acid 250 MG (SCDC, consists of)
acetohydroxamic acid 250 MG [Lithostat] (SBDC, consists of)
Oral Tablet (DF, has dose form)
Lithostat (BN, has ingredient)
acetohydroxamic acid 250 MG Oral Tablet (SCD, tradename of)

Linked data

NDCs

00178050001

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 213557 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/213557 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 213557. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.